U.S. MarketsIMPORTANT
Amgen Inc. (AMGN) Q3 2026 (USD): Adj. EPS 6.45 (exp. 5.79), Revenue 10.4bln (exp. 10.07bln), Adj. operating income 4.7bln (exp. 4.33bln)
ORIGINAL · NewsquawkAmgen Inc. (AMGN) Q3 2026 (USD): Adj. EPS 6.45 (exp. 5.79), Revenue 10.4bln (exp. 10.07bln), Adj. operating income 4.7bln (exp. 4.33bln)Read originalHide original
Guidance: FY revenue 38.9-39.7bln (exp. 39bln). FY adj. EPS 22.90-23.70 (exp. 23.06).
StockNow breaking-news AI analysis
Amgen’s reported Q3 2026 adjusted EPS, revenue and adjusted operating income exceeded listed expectations; FY guidance ranges included their listed expectations.
News detail
Guidance: FY revenue 38.9-39.7bln (exp. 39bln). FY adj. EPS 22.90-23.70 (exp. 23.06).
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
